Rua Bioscience (NZSE:RUA) Net Margin % : -63,835.29% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Rua Bioscience's Net Income for the six months ended in Dec. 2023 was NZ$-10.85 Mil. Rua Bioscience's Revenue for the six months ended in Dec. 2023 was NZ$0.02 Mil. Therefore, Rua Bioscience's net margin for the quarter that ended in Dec. 2023 was -63,835.29%.

The historical rank and industry rank for Rua Bioscience's Net Margin % or its related term are showing as below:

NZSE:RUA' s Net Margin % Range Over the Past 10 Years
Min: -35983.33 Med: -18823.93 Max: -1664.53
Current: -5618.59

NZSE:RUA's Net Margin % is ranked worse than
97.94% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.065 vs NZSE:RUA: -5618.59

Rua Bioscience Net Margin % Historical Data

The historical data trend for Rua Bioscience's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience Net Margin % Chart

Rua Bioscience Annual Data

Trend

Jun21

Jun22

Jun23

Net Margin %

-35,983.33

-1,664.53

Rua Bioscience Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial			-	-	1,141.27	-2,263.73	-63,835.29

Competitive Comparison of Rua Bioscience's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rua Bioscience's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's Net Margin % falls into.

Rua Bioscience Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rua Bioscience's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-5.959	/	0.358
	=	-1,664.53 %

Rua Bioscience's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-10.852	/	0.017
	=	-63,835.29 %

Rua Bioscience (NZSE:RUA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Rua Bioscience Net Margin % Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rua Bioscience (NZSE:RUA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Commerce Place, Awapuni, Gisborne, NZL, 4071

Website

https://www.ruabio.com

Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Germany and New Zealand.

Rua Bioscience (NZSE:RUA) Headlines

No Headlines